This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS). The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 and leading vaccines produced against COVID-19 infection. In the second part of the article, we discuss the effect of Disease Modifying Therapies (DMTs) on COVID-19 infection severity or SARS-CoV-2 vaccination in MS patients plus safety profile of different vaccine platforms in MS patients.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, multiple sclerosis, Immunosuppression, DMTs, 【초록키워드】 SARS-CoV-2 pandemic, severity, immunopathology, COVID-19 infection, Patient, vaccine platform, patients, safety profile, SARS-CoV-2 vaccination, produced, Modifying, 【제목키워드】 response, Impact, Multiple, sclerosis, Modifying,
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, multiple sclerosis, Immunosuppression, DMTs, 【초록키워드】 SARS-CoV-2 pandemic, severity, immunopathology, COVID-19 infection, Patient, vaccine platform, patients, safety profile, SARS-CoV-2 vaccination, produced, Modifying, 【제목키워드】 response, Impact, Multiple, sclerosis, Modifying,